Targeting glucosylceramide synthase synergizes with C₆-ceramide nanoliposomes to induce apoptosis in natural killer cell leukemia

References

• Alekshun TJ, Sokol L. Diseases of large granular lymphocytes. Cancer Control 2007;14:141–150.
   PubMedGoogle Scholar
• Zhang R, Shah MV, Loughran TP Jr. The root of many evils: indolent large granular lymphocyte leukaemia and associated disorders. Hematol Oncol 2010;28:105–117.
   PubMed Web of Science ®Google Scholar
• Chan WC, Link S, Mawle A, et al. Heterogeneity of large granular lymphocyte proliferations: delineation of two major subtypes. Blood 1986;68:1142–1153.
   PubMed Web of Science ®Google Scholar
• Lamy T, Loughran TP Jr. How I treat LGL leukemia. Blood 2011;117:2764–2774.
   PubMed Web of Science ®Google Scholar
• Shah MV, Zhang R, Irby R, et al. Molecular profiling of LGL leukemia reveals role of sphingolipid signaling in survival of cytotoxic lymphocytes. Blood 2008;112:770–781.
   PubMed Web of Science ®Google Scholar
• Birbes H, El Bawab S, Obeid LM, et al. Mitochondria and ceramide: intertwined roles in regulation of apoptosis. Adv Enzyme Regul 2002;42:113–129.
   PubMedGoogle Scholar
• Bourbon NA, Yun J, Kester M. Ceramide directly activates protein kinase C zeta to regulate a stress-activated protein kinase signaling complex. J Biol Chem 2000;275:35617–35623.
   PubMed Web of Science ®Google Scholar
• Hofmann K, Dixit VM. Ceramide in apoptosis--does it really matter?Trends Biochem Sci 1998;23:374–377.
   PubMed Web of Science ®Google Scholar
• Kolesnick RN, Kronke M. Regulation of ceramide production and apoptosis. Annu Rev Physiol 1998;60:643–665.
   PubMed Web of Science ®Google Scholar
• Lin X, Fuks Z, Kolesnick R. Ceramide mediates radiation-induced death of endothelium. Crit Care Med 2000;28(Suppl.): N87–N93.
   Google Scholar
• Bleicher RJ, Cabot MC. Glucosylceramide synthase and apoptosis. Biochim Biophys Acta 2002;1585:172–178.
   PubMed Web of Science ®Google Scholar
• Abe A, Inokuchi J, Jimbo M, et al. Improved inhibitors of glucosylceramide synthase. J Biochem 1992;111:191–196.
   PubMed Web of Science ®Google Scholar
• Kester M, Kolesnick R. Sphingolipids as therapeutics. Pharmacol Res 2003;47:365–371.
   PubMed Web of Science ®Google Scholar
• Messner MC, Cabot MC. Glucosylceramide in humans. Adv Exp Med Biol 2010;688:156–164.
   PubMed Web of Science ®Google Scholar
• Chapman JV, Gouaze-Andersson V, Messner MC, et al. Metabolism of short-chain ceramide by human cancer cells--implications for therapeutic approaches. Biochem Pharmacol 2010;80:308–315.
   PubMed Web of Science ®Google Scholar
• Xie P, Shen YF, Shi YP, et al. Overexpression of glucosylceramide synthase in associated with multidrug resistance of leukemia cells. Leuk Res 2008;32:475–480.
   PubMed Web of Science ®Google Scholar
• Barth BM, Cabot MC, Kester M. Ceramide-based therapeutics for the treatment of cancer. Anticancer Agents Med Chem 2011;11: 911–919.
   PubMed Web of Science ®Google Scholar
• Gouaze-Andersson V, Cabot MC. Sphingolipid metabolism and drug resistance in hematological malignancies. Anticancer Agents Med Chem 2011;11:891–903.
   PubMed Web of Science ®Google Scholar
• Liu X, Ryland L, Yang J, et al. Targeting of survivin by nanoliposomal ceramide induces complete remission in a rat model of NK-LGL leukemia. Blood 2010;116:4192–4201.
   PubMed Web of Science ®Google Scholar
• Stover TC, Sharma A, Robertson GP, et al. Systemic delivery of liposomal short-chain ceramide limits solid tumor growth in murine models of breast adenocarcinoma. Clin Cancer Res 2005;11: 3465–3474.
   PubMed Web of Science ®Google Scholar
• Tran MA, Smith CD, Kester M, et al. Combining nanoliposomal ceramide with sorafenib synergistically inhibits melanoma and breast cancer cell survival to decrease tumor development. Clin Cancer Res 2008;14:3571–3581.
   PubMed Web of Science ®Google Scholar
• Stover T, Kester M. Liposomal delivery enhances short-chain ceramide-induced apoptosis of breast cancer cells. J Pharmacol Exp Ther 2003;307:468–475.
   PubMed Web of Science ®Google Scholar
• Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959;37:911–917.
   PubMedGoogle Scholar
• Liao A, Broeg K, Fox T, et al. Therapeutic efficacy of FTY720 in a rat model of NK-cell leukemia. Blood 2011;118:2793–2800.
   PubMed Web of Science ®Google Scholar
• Fox TE, Bewley MC, Unrath KA, et al. Circulating sphingolipid biomarkers in models of type 1 diabetes. J Lipid Res 2011;52:509–517.
   PubMed Web of Science ®Google Scholar
• Ryland LK, Fox TE, Liu X, et al. Dysregulation of sphingolipid metabolism in cancer. Cancer Biol Ther 2011;11:138–149.
   PubMed Web of Science ®Google Scholar
• Jiang Y, DiVittore NA, Kaiser JM, et al. Combinatorial therapies improve the therapeutic efficacy of nanoliposomal ceramide for pancreatic cancer. Cancer Biol Ther 2011;12:57–585.
   Web of Science ®Google Scholar
• Liao A, Broeg K, Fox T, et al. Therapeutic efficacy of FTY720 in a rat model of natural killer cell leukemia. Blood 2011;118:2793–2800.
   PubMed Web of Science ®Google Scholar
• Di Paola M, Cocco T, Lorusso M. Ceramide interaction with the respiratory chain of heart mitochondria. Biochemistry 2000;39: 6660–6668.
   PubMed Web of Science ®Google Scholar
• Garcia-Ruiz C, Colell A, Mari M, et al. Direct effect of ceramide on the mitochondrial electron transport chain leads to generation of reactive oxygen species. Role of mitochondrial glutathione. J Biol Chem 1997;272:11369–11377.
   PubMed Web of Science ®Google Scholar
• Hildeman DA, Mitchell T, Aronow B, et al. Control of Bcl-2 expression by reactive oxygen species. Proc Natl Acad Sci USA 2003;100:15035–15040.
   PubMed Web of Science ®Google Scholar
• Li D, Ueta E, Kimura T, et al. Reactive oxygen species (ROS) control the expression of Bcl-2 family proteins by regulating their phosphorylation and ubiquitination. Cancer Sci 2004;95:644–650.
   PubMed Web of Science ®Google Scholar
• Kozopas KM, Yang T, Buchan HL, et al. MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2. Proc Natl Acad Sci USA 1993;90:3516–3520.
   PubMed Web of Science ®Google Scholar
• Sato T, Hanada M, Bodrug S, et al. Interactions among members of the Bcl-2 protein family analyzed with a yeast two-hybrid system. Proc Natl Acad Sci USA 1994;91:9238–9242.
   PubMed Web of Science ®Google Scholar
• Yang T, Kozopas KM, Craig RW. The intracellular distribution and pattern of expression of Mcl-1 overlap with, but are not identical to, those of Bcl-2. J Cell Biol 1995;128:1173–1184.
   PubMed Web of Science ®Google Scholar
• Epling-Burnette PK, Liu JH, Catlett-Falcone R, et al. Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. J Clin Invest 2001; 107:351–362.
   PubMed Web of Science ®Google Scholar
• Shabbits JA, Mayer LD. Intracellular delivery of ceramide lipids via liposomes enhances apoptosis in vitro. Biochim Biophys Acta 2003;1612:98–106.
   PubMed Web of Science ®Google Scholar
• Khazanov E, Priev A, Shillemans JP, et al. Physicochemical and biological characterization of ceramide-containing liposomes: paving the way to ceramide therapeutic application. Langmuir 2008;24: 6965–6980.
   PubMed Web of Science ®Google Scholar
• Tokudome Y, Saito Y, Sato F, et al. Preparation and characterization of ceramide-based liposomes with high fusion activity and high membrane fluidity. Colloids Surf B Biointerfaces 2009;73:92–96.
   PubMed Web of Science ®Google Scholar
• Lavie Y, Cao H, Volner A, et al. Agents that reverse multidrug resistance, tamoxifen, verapamil, and cyclosporin A, block glycosphingolipid metabolism by inhibiting ceramide glycosylation in human cancer cells. J Biol Chem 1997;272:1682–1687.
   PubMed Web of Science ®Google Scholar
• Liu Y, Xie KM, Yang GQ, et al. GCS induces multidrug resistance by regulating apoptosis-related genes in K562/AO2 cell line. Cancer Chemother Pharmacol 2010;66:433–439.
   PubMed Web of Science ®Google Scholar
• Novgorodov SA, Wu BX, Gudz TI, et al. Novel pathway of ceramide production in mitochondria: thioesterase and neutral ceramidase produce ceramide from sphingosine and acyl-CoA. J Biol Chem 2011;286:25352–25362.
   PubMed Web of Science ®Google Scholar
• Kroemer G, Dallaporta B, Resche-Rigon M. The mitochondrial death/life regulator in apoptosis and necrosis. Annu Rev Physiol 1998;60:619–642.
   PubMed Web of Science ®Google Scholar
• Kroemer G, Galluzzi L, Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol Rev 2007;87:99–163.
   PubMed Web of Science ®Google Scholar
• Nica AF, Tsao CC, Watt JC, et al. Ceramide promotes apoptosis in chronic myelogenous leukemia-derived K562 cells by a mechanism involving caspase-8 and JNK. Cell Cycle 2008;7:3362–3370.
   PubMed Web of Science ®Google Scholar